Clinical Trial Update: PARA (Pancreatic Adenocarcinoma Etiology: Role of Asbestos) Study of Risk Factors for Exocrine Pancreatic Neoplasms.

View source ↗

Summary

This clinical trial update describes the PARA study on risk factors for exocrine pancreatic neoplasms, focusing on pancreatic adenocarcinoma. The trial status i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Snippet

Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna | Conditions: Pancreatic Adenocarcinoma | Status: ACTIVE_NOT_RECRUITING